Metabolomics Workbench : NIH Data Repository

MB Sample ID: SA308642

Local Sample ID:	tumor-enzalutamide-3-01
Subject ID:	SU002964
Subject Type:	Mammal
Subject Species:	Mus musculus
Genotype Strain:	NSG

Select appropriate tab below to view additional metadata details:

All
Subject
Factors
Collection
Treatment
Sample Preparation
Chromatography
Analysis
MS

Treatment:

Treatment ID:	TR002973
Treatment Summary:	7 million 16D cells were implanted subcutaneously with 100 μl Matrigel (Corning) into NSG mice to form primary tumors. Primary tumors were harvested, minced, and re-implanted (20 - 80 mg of minced tumor tissue with 100 μl Matrigel per mouse) into NSG mice. 16D tumor-bearing mice were treated by oral gavage with 10 mg/kg/day of Enzalutamide in the vehicle (1% carboxymethyl cellulose, 0.5% Tween 80, and 5% dimethylsulfoxide) or the vehicle only, with a two-days-on/one-day-off schedule.

Treatment ID:

TR002973

Treatment Summary:

7 million 16D cells were implanted subcutaneously with 100 μl Matrigel (Corning) into NSG mice to form primary tumors. Primary tumors were harvested, minced, and re-implanted (20 - 80 mg of minced tumor tissue with 100 μl Matrigel per mouse) into NSG mice. 16D tumor-bearing mice were treated by oral gavage with 10 mg/kg/day of Enzalutamide in the vehicle (1% carboxymethyl cellulose, 0.5% Tween 80, and 5% dimethylsulfoxide) or the vehicle only, with a two-days-on/one-day-off schedule.